{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T03:47:10Z","timestamp":1790567230177,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T00:00:00Z","timestamp":1673136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T00:00:00Z","timestamp":1673136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    To depict the spectrum of rheumatoid arthritis (RA) in Egypt in relation to other universal studies to provide broad-based characteristics to this particular population. This work included 10,364 adult RA patients from 26 specialized Egyptian rheumatology centers representing 22 major cities all over the country. The demographic and clinical features as well as therapeutic data were assessed. The mean age of the patients was 44.8\u2009\u00b1\u200911.7\u00a0years, disease duration 6.4\u2009\u00b1\u20096\u00a0years, and age at onset 38.4\u2009\u00b1\u200911.6\u00a0years; 209 (2%) were juvenile-onset. They were 8750 females and 1614 males (F:M 5.4:1). 8% were diabetic and 11.5% hypertensive. Their disease activity score (DAS28) was 4.4\u2009\u00b1\u20091.4 and health assessment questionnaire (HAQ) 0.95\u2009\u00b1\u20090.64. The rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) were positive in 73.7% and 66.7% respectively. Methotrexate was the most used treatment (78%) followed by hydroxychloroquine (73.7%) and steroids (71.3%). Biologic therapy was received by 11.6% with a significantly higher frequency by males vs females (15.7% vs 10.9%,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.001). The least age at onset, F:M, RF and anti-CCP positivity were present in Upper Egypt (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001), while the highest DAS28 was reported in Canal cities and Sinai (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001). The HAQ was significantly increased in Upper Egypt with the least disability in Canal cities and Sinai (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.001). Biologic therapy intake was higher in Lower Egypt followed by the Capital (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001). The spectrum of RA phenotype in Egypt is variable across the country with an increasing shift in the F:M ratio. The age at onset was lower than in other countries.\n                  <\/jats:p>","DOI":"10.1007\/s00296-022-05258-2","type":"journal-article","created":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T00:04:48Z","timestamp":1673136288000},"page":"667-676","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Rheumatoid arthritis study of the Egyptian College of Rheumatology (ECR): nationwide presentation and worldwide stance"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1155-9729","authenticated-orcid":false,"given":"Tamer A.","family":"Gheita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7555-3609","authenticated-orcid":false,"given":"Hala A.","family":"Raafat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3141-6079","authenticated-orcid":false,"given":"Samah A.","family":"El-Bakry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5759-2009","authenticated-orcid":false,"given":"Ahmed","family":"Elsaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5644-0994","authenticated-orcid":false,"given":"Hanan M.","family":"El-Saadany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7754-5581","authenticated-orcid":false,"given":"Nevin","family":"Hammam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9493-890X","authenticated-orcid":false,"given":"Iman I.","family":"El-Gazzar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3291-1103","authenticated-orcid":false,"given":"Nermeen","family":"Samy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9432-2403","authenticated-orcid":false,"given":"Nora Y.","family":"Elsaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7200-1083","authenticated-orcid":false,"given":"Suzan S.","family":"Al-Adle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9892-2449","authenticated-orcid":false,"given":"Samar","family":"Tharwat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0292-1474","authenticated-orcid":false,"given":"Amira M.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9314-3005","authenticated-orcid":false,"given":"Samar M.","family":"Fawzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6981-3470","authenticated-orcid":false,"given":"Nahla N.","family":"Eesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1071-6358","authenticated-orcid":false,"given":"Rawhya El","family":"Shereef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7315-4524","authenticated-orcid":false,"given":"Faten","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7164-0652","authenticated-orcid":false,"given":"Mervat I Abd","family":"Elazeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2659-0825","authenticated-orcid":false,"given":"Enas A.","family":"Abdelaleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5804-774X","authenticated-orcid":false,"given":"Amany","family":"El-Bahnasawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1325-1402","authenticated-orcid":false,"given":"Zahraa I.","family":"Selim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9340-0024","authenticated-orcid":false,"given":"Nada M.","family":"Gamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2240-5792","authenticated-orcid":false,"given":"Maha","family":"Nassr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8875-2455","authenticated-orcid":false,"given":"Samah I.","family":"Nasef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7291-3616","authenticated-orcid":false,"given":"Abdel Hafeez","family":"Moshrif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9477-9200","authenticated-orcid":false,"given":"Shereen","family":"Elwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5692-3483","authenticated-orcid":false,"given":"Yousra H.","family":"Abdel-Fattah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0967-5747","authenticated-orcid":false,"given":"Marwa A.","family":"Amer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1220-7215","authenticated-orcid":false,"given":"Doaa","family":"Mosad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6442-9963","authenticated-orcid":false,"given":"Eman F.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7444-4259","authenticated-orcid":false,"given":"Dina F.","family":"El-Essawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5547-8429","authenticated-orcid":false,"given":"Hanan","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9792-6189","authenticated-orcid":false,"given":"Mohamed N.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2011-3144","authenticated-orcid":false,"given":"Rasha M.","family":"Fawzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2577-1111","authenticated-orcid":false,"given":"Maha E.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6557-3956","authenticated-orcid":false,"given":"Asmaa","family":"Khalifa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1552-9444","authenticated-orcid":false,"given":"Nouran M.","family":"Abaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7147-7867","authenticated-orcid":false,"given":"Ahmed M.","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2498-0050","authenticated-orcid":false,"given":"Amany R.","family":"El-Najjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4992-7080","authenticated-orcid":false,"given":"Noha A.","family":"Azab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1964-305X","authenticated-orcid":false,"given":"Hanan M.","family":"Fathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3134-7264","authenticated-orcid":false,"given":"Khaled","family":"El-Hadidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5252-6405","authenticated-orcid":false,"given":"Tahsin","family":"El-Hadidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The Egyptian College of Rheumatology (ECR) Rheumatoid Arthritis Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,8]]},"reference":[{"key":"5258_CR1","volume-title":"StatPearls [Internet]","author":"K Chauhan","year":"2021","unstructured":"Chauhan K, Jandu JS, Goyal A, Bansal P, Al-Dhahir MA (2021) Rheumatoid arthritis. StatPearls [Internet]. Stat Pearls Publishing, Treasure Island (FL)"},{"issue":"20","key":"5258_CR2","doi-asserted-by":"publisher","first-page":"10922","DOI":"10.3390\/ijms222010922","volume":"22","author":"N Kondo","year":"2021","unstructured":"Kondo N, Kuroda T, Kobayashi D (2021) Cytokine networks in the pathogenesis of rheumatoid arthritis. Int J Mol Sci 22(20):10922","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5258_CR3","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s12016-021-08890-1","volume":"63","author":"MV Sokolova","year":"2022","unstructured":"Sokolova MV, Schett G, Steffen U (2022) Autoantibodies in rheumatoid arthritis: historical background and novel findings. Clin Rev Allergy Immunol 63(2):138\u2013151","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"5258_CR4","volume":"92","author":"F Salaffi","year":"2021","unstructured":"Salaffi F, Di Carlo M, Farah S, Marotto D, Atzeni F, Sarzi-Puttini P (2021) Rheumatoid arthritis disease activity assessment in routine care: performance of the most widely used composite disease activity indices and patient-reported outcome measures. Acta Biomed 92(4):e2021238","journal-title":"Acta Biomed"},{"issue":"1","key":"5258_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.semarthrit.2010.03.003","volume":"40","author":"JR Curtis","year":"2010","unstructured":"Curtis JR, Jain A, Askling J, Bridges SL Jr, Carmona L, Dixon W et al (2010) A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries. Semin Arthritis Rheum 40(1):2-14.e1","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"5258_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-001653","volume":"7","author":"J Heutz","year":"2021","unstructured":"Heutz J, de Jong PHP (2021) Possibilities for personalised medicine in rheumatoid arthritis: hype or hope. RMD Open 7(3):e001653","journal-title":"RMD Open"},{"issue":"9","key":"5258_CR7","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd et al (2010) 2010 Rheumatoid arthritis classification criteria: an American college of rheumatology\/ European league against rheumatism collaborative initiative. Arthritis Rheum 62(9):2569\u20132581","journal-title":"Arthritis Rheum"},{"issue":"1","key":"5258_CR8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van\u2019t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38(1):44\u201348","journal-title":"Arthritis Rheum"},{"key":"5258_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1477-7525-1-20","volume":"1","author":"B Bruce","year":"2003","unstructured":"Bruce B, Fries JF (2003) The Stanford health assessment questionnaire: dimensions and practical applications. Health Qual Life Outcomes 1:20","journal-title":"Health Qual Life Outcomes"},{"issue":"12","key":"5258_CR10","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1093\/rheumatology\/kez188","volume":"58","author":"PDH Hamann","year":"2019","unstructured":"Hamann PDH, Pauling JD, McHugh N, Shaddick G, Hyrich K, BSRBR-RA Contributors Group (2019) Predictors, demographics and frequency of sustained remission and low disease activity in anti-tumour necrosis factor-treated rheumatoid arthritis patients. Rheumatology (Oxford) 58(12):2162\u20132169","journal-title":"Rheumatology (Oxford)"},{"key":"5258_CR11","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ebiom.2016.08.024","volume":"11","author":"DS Courvoisier","year":"2016","unstructured":"Courvoisier DS, Alpizar-Rodriguez D, Gottenberg JE, Hernandez MV, Iannone F, Lie E et al (2016) Rheumatoid arthritis patients after initiation of a new biologic agent: trajectories of disease activity in a large multinational cohort study. EBioMedicine 11:302\u2013306","journal-title":"EBioMedicine"},{"issue":"2","key":"5258_CR12","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s40744-021-00407-8","volume":"9","author":"PJ Mease","year":"2022","unstructured":"Mease PJ, Bhutani MK, Hass S, Yi E, Hur P, Kim N (2022) Comparison of clinical manifestations in rheumatoid arthritis vs. spondyloarthritis: a systematic literature review. Rheumatol Ther 9(2):331\u2013378","journal-title":"Rheumatol Ther"},{"key":"5258_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2147\/OARRR.S270700","volume":"12","author":"P Santos-Moreno","year":"2020","unstructured":"Santos-Moreno P, Castillo P, Villareal L, Pineda C, Sandoval H, Valencia O (2020) Clinical outcomes of patients with rheumatoid arthritis treated in a disease management program: real-world results. Open Access Rheumatol 12:249\u2013256","journal-title":"Open Access Rheumatol"},{"issue":"12","key":"5258_CR14","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1097\/CM9.0000000000001517","volume":"134","author":"X Song","year":"2021","unstructured":"Song X, Wang YH, Li MT, Duan XW, Li HB, Zeng XF, Co-authors of CREDIT (2021) Chinese registry of rheumatoid arthritis: IV. Correlation and consistency of rheumatoid arthritis disease activity indices in China. Chin Med J (Engl) 134(12):1465\u20131470","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"5258_CR15","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s13075-017-1457-z","volume":"19","author":"S Jin","year":"2017","unstructured":"Jin S, Li M, Fang Y, Li Q, Liu J, CREDIT Co-authors (2017) Chinese registry of rheumatoid arthritis (CREDIT): II. Prevalence and risk factors of major comorbidities in Chinese patients with rheumatoid arthritis. Arthritis Res Ther 19(1):251","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"5258_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0208240","volume":"13","author":"SR Dargham","year":"2018","unstructured":"Dargham SR, Zahirovic S, Hammoudeh M, Al Emadi S, Masri BK, Halabi H et al (2018) Epidemiology and treatment patterns of rheumatoid arthritis in a large cohort of Arab patients. PLoS ONE 13(12):e0208240","journal-title":"PLoS ONE"},{"issue":"3","key":"5258_CR17","doi-asserted-by":"publisher","first-page":"272","DOI":"10.5606\/ArchRheumatol.2016.5761","volume":"31","author":"FF Ayhan","year":"2016","unstructured":"Ayhan FF, Ataman \u015e, Rezvani A, Paker N, Ta\u015ftekin N, Kaya T et al (2016) Obesity associated with active, but preserved joints in rheumatoid arthritis: results from our national registry. Arch Rheumatol 31(3):272\u2013280","journal-title":"Arch Rheumatol"},{"key":"5258_CR18","unstructured":"Youth UNPo (2011) Regional overview: youth in the Arab region"},{"issue":"8","key":"5258_CR19","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1007\/s10067-019-04516-2","volume":"38","author":"R Ranza","year":"2019","unstructured":"Ranza R, de la Vega MC, Laurindo IMM, G\u00f3mez MG, Titton DC, Kakehasi AM et al (2019) Changing rate of serious infections in biologic-exposed rheumatoid arthritis patients. Data from South American registries BIOBADABRASIL and BIOBADASAR. Clin Rheumatol 38(8):2129\u20132139","journal-title":"Clin Rheumatol"},{"issue":"9","key":"5258_CR20","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.1007\/s10067-021-05710-x","volume":"40","author":"JC Castillo-Ca\u00f1\u00f3n","year":"2021","unstructured":"Castillo-Ca\u00f1\u00f3n JC, Trujillo-C\u00e1ceres SJ, Bautista-Molano W, Valbuena-Garc\u00eda AM, Fern\u00e1ndez-\u00c1vila DG, Acu\u00f1a-Merch\u00e1n L (2021) Rheumatoid arthritis in Colombia: a clinical profile and prevalence from a national registry. Clin Rheumatol 40(9):3565\u20133573","journal-title":"Clin Rheumatol"},{"issue":"8","key":"5258_CR21","first-page":"1254","volume":"56","author":"D Alp\u00edzar-Rodr\u00edguez","year":"2017","unstructured":"Alp\u00edzar-Rodr\u00edguez D, Pluchino N, Canny G, Gabay C, Finckh A (2017) The role of female hormonal factors in the development of rheumatoid arthritis. Rheumatology 56(8):1254\u20131263","journal-title":"Rheumatology"},{"issue":"1","key":"5258_CR22","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12931-021-01856-z","volume":"22","author":"M Qiu","year":"2021","unstructured":"Qiu M, Jiang J, Nian X, Wang Y, Yu P, Song J et al (2021) Factors associated with mortality in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis. Respir Res 22(1):264","journal-title":"Respir Res"},{"issue":"7","key":"5258_CR23","first-page":"1280","volume":"40","author":"B Zheng","year":"2022","unstructured":"Zheng B, de Soares MC, Machado M, Pineau CA, Curtis JR, Vinet E, Bernatsky S (2022) Association between chronic obstructive pulmonary disease, smoking, and interstitial lung disease onset in rheumatoid arthritis. Clin Exp Rheumatol 40(7):1280\u20131284","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"5258_CR24","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s10067-021-05967-2","volume":"41","author":"Y Geng","year":"2022","unstructured":"Geng Y, Gao T, Zhang X, Wang Y, Zhang Z (2022) The association between disease duration and mood disorders in rheumatoid arthritis patients. Clin Rheumatol 41(3):661\u2013668","journal-title":"Clin Rheumatol"},{"issue":"10","key":"5258_CR25","first-page":"1042","volume":"11","author":"E Rezu\u0219","year":"2021","unstructured":"Rezu\u0219 E, Macovei LA, Burlui AM, Cardoneanu A, Rezu\u0219 C (2021) Ischemic heart disease and rheumatoid arthritis-two conditions, the same background. Life (Basel) 11(10):1042","journal-title":"Life (Basel)"},{"key":"5258_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab710","author":"JF Baker","year":"2021","unstructured":"Baker JF, Giles JT, Weber D, George MD, Leonard MB, Zemel BS et al (2021) Sarcopenic obesity in rheumatoid arthritis: prevalence and impact on physical functioning. Rheumatology (Oxford). https:\/\/doi.org\/10.1093\/rheumatology\/keab710","journal-title":"Rheumatology (Oxford)"},{"key":"5258_CR27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ejim.2021.10.001","volume":"96","author":"F Cacciapaglia","year":"2022","unstructured":"Cacciapaglia F, Spinelli FR, Piga M, Erre GL, Sakellariou G, Manfredi A et al (2022) Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: data from the cardiovascular obesity and rheumatic disease (CORDIS) study group. Eur J Intern Med 96:60\u201365","journal-title":"Eur J Intern Med"},{"issue":"3","key":"5258_CR28","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s10067-021-05945-8","volume":"41","author":"JY Hee","year":"2022","unstructured":"Hee JY, Protani MM, Koh ET, Leong KP, Seng TT, Hospital Rheumatoid Arthritis Study Group (2022) Metabolic syndrome and its effect on the outcomes of rheumatoid arthritis in a multi-ethnic cohort in Singapore. Clin Rheumatol 41(3):649\u2013660","journal-title":"Clin Rheumatol"},{"issue":"6","key":"5258_CR29","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.semarthrit.2011.09.007","volume":"41","author":"YK Sung","year":"2012","unstructured":"Sung YK, Cho SK, Choi CB, Park SY, Shim J, Ahn JK et al (2012) Korean observational study network for arthritis (KORONA): establishment of a prospective multicenter cohort for rheumatoid arthritis in South Korea. Semin Arthritis Rheum 41(6):745\u2013751","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"5258_CR30","doi-asserted-by":"publisher","first-page":"300060521104771","DOI":"10.1177\/03000605211047714","volume":"49","author":"X Yang","year":"2021","unstructured":"Yang X, Cai Y, Xue B, Zhang B (2021) Diagnostic value of anti-cyclic citrullinated peptide antibody combined with rheumatoid factor in rheumatoid arthritis in Asia: a meta-analysis. J Int Med Res 49(9):3000605211047714","journal-title":"J Int Med Res"},{"key":"5258_CR31","first-page":"99","volume":"318","author":"O Iaremenko","year":"2021","unstructured":"Iaremenko O, Mykytenko G (2021) Achievement of clinical remission in patients with rheumatoid arthritis depending on the ACCP-and RF-serological status. Georgian Med News 318:99\u2013104","journal-title":"Georgian Med News"},{"issue":"3","key":"5258_CR32","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s10067-021-05961-8","volume":"41","author":"KS Bywall","year":"2022","unstructured":"Bywall KS, Esbensen BA, Lason M, Heidenvall M, Erlandsson I, Johansson JV (2022) Functional capacity vs side effects: treatment attributes to consider when individualising treatment for patients with rheumatoid arthritis. Clin Rheumatol 41(3):695\u2013704","journal-title":"Clin Rheumatol"},{"issue":"2","key":"5258_CR33","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/annrheumdis-2021-220853","volume":"81","author":"D Capelusnik","year":"2022","unstructured":"Capelusnik D, Aletaha D (2022) Baseline predictors of different types of treatment success in rheumatoid arthritis. Ann Rheum Dis 81(2):153\u2013158","journal-title":"Ann Rheum Dis"},{"key":"5258_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-021-01086-0","author":"N Pardey","year":"2021","unstructured":"Pardey N, Zeidler J, Nellenschulte TF, Stahmeyer JT, Hoeper K, Witte T (2021) Methotrexate treatment before use of biologics in rheumatoid arthritis: analysis of guideline compliance. Z Rheumatol. https:\/\/doi.org\/10.1007\/s00393-021-01086-0","journal-title":"Z Rheumatol"},{"issue":"9","key":"5258_CR35","volume":"13","author":"A Siddiqui","year":"2021","unstructured":"Siddiqui A, Totonchian A, Ali JB, Ahmad I, Kumar J, Shiwlani S et al (2021) Risk factors associated with non-respondence to methotrexate in rheumatoid arthritis patients. Cureus 13(9):e18112","journal-title":"Cureus"},{"issue":"5","key":"5258_CR36","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00296-021-04994-1","volume":"42","author":"PJ Belani","year":"2022","unstructured":"Belani PJ, Kavadichanda CG, Negi VS (2022) Comparison between leflunomide and sulfasalazine based triple therapy in methotrexate refractory rheumatoid arthritis: an open-label, non-inferiority randomized controlled trial. Rheumatol Int 42(5):771\u2013782","journal-title":"Rheumatol Int"},{"issue":"9","key":"5258_CR37","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000019415","volume":"99","author":"SK Kim","year":"2020","unstructured":"Kim SK, Kwak SG, Choe JY (2020) Association between biologic disease modifying anti-rheumatic drugs and incident hypertension in patients with rheumatoid arthritis: results from prospective nationwide KOBIO registry. Medicine (Baltimore) 99(9):e19415","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"5258_CR38","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s41927-021-00216-0","volume":"5","author":"G Huang","year":"2021","unstructured":"Huang G, Cai J, Li W, Zhong Y, Liao W, Wu P (2021) Causal relationship between educational attainment and the risk of rheumatoid arthritis: a Mendelian randomization study. BMC Rheumatol 5(1):47","journal-title":"BMC Rheumatol"},{"key":"5258_CR39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2147\/OARRR.S260426","volume":"12","author":"H Almoallim","year":"2020","unstructured":"Almoallim H, Hassan R, Cheikh M, Faruqui H, Alquraa R, Eissa A et al (2020) Rheumatoid arthritis Saudi database (RASD): disease characteristics and remission rates in a tertiary care center. Open Access Rheumatol 12:139\u2013145","journal-title":"Open Access Rheumatol"},{"key":"5258_CR40","first-page":"183","volume":"38","author":"M Eddaoudi","year":"2021","unstructured":"Eddaoudi M, Rostom S, Hmamouchi I, Binoune IE, Amine B, Abouqal R et al (2021) The first biological choice in patients with rheumatoid arthritis: data from the Moroccan register of biotherapies. Pan Afr Med J 38:183","journal-title":"Pan Afr Med J"},{"issue":"1","key":"5258_CR41","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12955-021-01874-x","volume":"19","author":"SW Al-Jabi","year":"2021","unstructured":"Al-Jabi SW, Seleit DI, Badran A, Koni A, Zyoud SH (2021) Impact of socio-demographic and clinical characteristics on functional disability and health-related quality of life in patients with rheumatoid arthritis: a cross-sectional study from Palestine. Health Qual Life Outcomes 19(1):241","journal-title":"Health Qual Life Outcomes"},{"key":"5258_CR42","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2147\/OARRR.S322833","volume":"13","author":"M AlOmair","year":"2021","unstructured":"AlOmair M, AlMalki H, AlShamrani N, Habtar G, AlAsmari M, Mobasher W et al (2021) Patterns of response to different treatment strategies in seropositive rheumatoid arthritis patients in a tertiary hospital in south-western Saudi Arabia: a retrospective study. Open Access Rheumatol 13:239\u2013246","journal-title":"Open Access Rheumatol"},{"issue":"2","key":"5258_CR43","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10067-021-05944-9","volume":"41","author":"CH Suh","year":"2022","unstructured":"Suh CH, Lee K, Kim JW, Boo S (2022) Factors affecting quality of life in patients with rheumatoid arthritis in South Korea: a cross-sectional study. Clin Rheumatol 41(2):367\u2013375","journal-title":"Clin Rheumatol"},{"issue":"2","key":"5258_CR44","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.semarthrit.2019.08.008","volume":"50","author":"S Hawley","year":"2020","unstructured":"Hawley S, Edwards CJ, Arden NK, Delmestri A, Cooper C, Judge A et al (2020) Descriptive epidemiology of hip and knee replacement in rheumatoid arthritis: an analysis of UK electronic medical records. Semin Arthritis Rheum 50(2):237\u2013244","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"5258_CR45","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1136\/annrheumdis-2016-209285","volume":"76","author":"LK Mercer","year":"2017","unstructured":"Mercer LK, Askling J, Raaschou P, Dixon WG, Dreyer L, Hetland ML et al (2017) Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers. Ann Rheum Dis 76(2):386\u2013391","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"5258_CR46","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s13075-021-02617-5","volume":"23","author":"MN Peterson","year":"2021","unstructured":"Peterson MN, Dykhoff HJ, Crowson CS, Davis JM 3rd, Sangaralingham LR, Myasoedova E (2021) Risk of rheumatoid arthritis diagnosis in statin users in a large nationwide US study. Arthritis Res Ther 23(1):244","journal-title":"Arthritis Res Ther"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-022-05258-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-022-05258-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-022-05258-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T23:33:32Z","timestamp":1678318412000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-022-05258-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,8]]},"references-count":46,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["5258"],"URL":"https:\/\/doi.org\/10.1007\/s00296-022-05258-2","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,8]]},"assertion":[{"value":"16 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}